PRDO
Price
$28.96Alerts
Change
+$0.09 (+0.31%)
Updated
Nov 11 closing price
Capitalization
1.68B
106 days until earnings call
Intraday BUY SELL Signals
UTI
Price
$23.00Alerts
Change
-$0.21 (-0.90%)
Updated
Nov 11, 04:59 PM (EDT)
Capitalization
1.1B
7 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PRDO vs UTI

PRDO vs UTI Comparison Chart in %
View a ticker or compare two or three
VS
PRDO vs. UTI commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRDO is a Hold and UTI is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for PRDO with price predictions
Nov 10, 2026

PRDO in upward trend: price may jump up because it broke its lower Bollinger Band on November 05, 2026

PRDO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 30 of 40 cases where PRDO's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 75%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PRDO's RSI Oscillator exited the oversold zone, 16 of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +7.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where PRDO advanced for three days, in 237 of 347 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PRDO as a result. In 52 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.

The Moving Average Convergence Divergence Histogram (MACD) for PRDO turned negative on October 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 35 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.

PRDO moved below its 50-day moving average on October 27, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PRDO crossed bearishly below the 50-day moving average on October 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 75%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRDO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.

The Aroon Indicator for PRDO entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 24 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 51 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.628) is normal, around the industry mean (1.158). P/E Ratio (9.566) is within average values for comparable stocks, (8.484). Projected Growth (PEG Ratio) (0.606) is also within normal values, averaging (1.327). Dividend Yield (0.025) settles around the average of (4.151) among similar stocks. P/S Ratio (2.499) is also within normal values, averaging (27.566).

The Tickeron Price Growth Rating for this company is 73 (best 1 - 100 worst), indicating slightly worse than average price growth. PRDO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 79 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
a Summary for UTI with price predictions
Nov 10, 2026

UTI in upward trend: 10-day moving average moved above 50-day moving average on October 27, 2026

The 10-day moving average for UTI crossed bullishly above the 50-day moving average on October 27, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 10, 2026. You may want to consider a long position or call options on UTI as a result. In 75 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.

The Moving Average Convergence Divergence (MACD) for UTI just turned positive on November 10, 2026. Looking at past instances where UTI's MACD turned positive, the stock continued to rise in 34 of 45 cases over the following month. The odds of a continued upward trend are 76%.

UTI moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +16.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where UTI advanced for three days, in 259 of 330 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

UTI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 185 of 250 cases where UTI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.

Bearish Trend Analysis

The 10-day RSI Indicator for UTI moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In 33 of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 51 of 68 cases where UTI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 75%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UTI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. UTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 66 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock slightly better than average.

The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: UTI's P/B Ratio (3.189) is slightly higher than the industry average of (1.158). UTI has a moderately high P/E Ratio (32.145) as compared to the industry average of (8.484). Projected Growth (PEG Ratio) (1.642) is also within normal values, averaging (1.327). Dividend Yield (0.004) settles around the average of (4.151) among similar stocks. P/S Ratio (1.320) is also within normal values, averaging (27.566).

FUNDAMENTALS RATINGS
PRDO vs UTI: Fundamental Ratings
PRDO
UTI
OUTLOOK RATING
1..100
7740
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
85
Overvalued
PROFIT vs RISK RATING
1..100
2466
SMR RATING
1..100
5168
PRICE GROWTH RATING
1..100
7362
P/E GROWTH RATING
1..100
7916
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRDO's Valuation (64) in the null industry is in the same range as UTI (85) in the Miscellaneous Commercial Services industry. This means that PRDO’s stock grew similarly to UTI’s over the last 12 months.

PRDO's Profit vs Risk Rating (24) in the null industry is somewhat better than the same rating for UTI (66) in the Miscellaneous Commercial Services industry. This means that PRDO’s stock grew somewhat faster than UTI’s over the last 12 months.

PRDO's SMR Rating (51) in the null industry is in the same range as UTI (68) in the Miscellaneous Commercial Services industry. This means that PRDO’s stock grew similarly to UTI’s over the last 12 months.

UTI's Price Growth Rating (62) in the Miscellaneous Commercial Services industry is in the same range as PRDO (73) in the null industry. This means that UTI’s stock grew similarly to PRDO’s over the last 12 months.

UTI's P/E Growth Rating (16) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for PRDO (79) in the null industry. This means that UTI’s stock grew somewhat faster than PRDO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PRDOUTI
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 10 days ago
63%
Bearish Trend 9 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
44%
Bullish Trend 2 days ago
74%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (PRDO: $28.87 vs. UTI: $23.21)
Brand notoriety: PRDO and UTI are both not notable
Both companies represent the Other Consumer Specialties industry
Current volume relative to the 65-day Moving Average: PRDO: 126% vs. UTI: 102%
Market capitalization -- PRDO: $1.68B vs. UTI: $1.1B
PRDO [@Other Consumer Specialties] is valued at $1.68B. UTI’s [@Other Consumer Specialties] market capitalization is $1.1B. The market cap for tickers in the [@Other Consumer Specialties] industry ranges from $90 to $15B. The average market capitalization across the [@Other Consumer Specialties] industry is $1.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRDO’s FA Score shows that 1 FA rating(s) are green while UTI’s FA Score has 1 green FA rating(s).

  • PRDO’s FA Score: 1 green, 4 red.
  • UTI’s FA Score: 1 green, 4 red.
According to our system of comparison, both PRDO and UTI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRDO’s TA Score shows that 4 TA indicator(s) are bullish while UTI’s TA Score has 7 bullish TA indicator(s).

  • PRDO’s TA Score: 4 bullish, 6 bearish.
  • UTI’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, UTI is a better buy in the short-term than PRDO.

Price Growth

PRDO (@Other Consumer Specialties) experienced а -2.66% price change this week, while UTI (@Other Consumer Specialties) price change was +6.96% for the same time period.

The average weekly price growth across all stocks in the @Other Consumer Specialties industry was -6.64%. For the same industry, the average monthly price growth was -18.67%, and the average quarterly price growth was -26.17%.

Reported Earning Dates

PRDO is expected to report earnings on Feb 25, 2027.

UTI is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Other Consumer Specialties (-6.64% weekly)

‘Other Consumer Specialties’ represents an industry that typically sells durable consumer products, but do not have a classification in another category. The products include jewelry, smoke detectors, watches, collectibles and safety products. MSA Safety (makes products which enhances the safety and health of workers and protect facility infrastructures), Matthews International (memorialization business), Fitbit (makes wireless-enabled wearable technology devices that gauge data such as the number of steps walked, heart rate, quality of sleep), and Fossil Group (makes watches and accessories) have some of the largest market caps in this group.

View a ticker or compare two or three
Interact to see
Advertisement

PRDO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRDO has been closely correlated with LOPE. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if PRDO jumps, then LOPE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRDO
1D Price
Change %
PRDO100%
+5.21%
LOPE - PRDO
74%
Closely correlated
+0.29%
CVSA - PRDO
73%
Closely correlated
+2.21%
STRA - PRDO
73%
Closely correlated
+3.10%
APEI - PRDO
72%
Closely correlated
+2.84%
LINC - PRDO
57%
Loosely correlated
+4.55%
More

UTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTI has been loosely correlated with LINC. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if UTI jumps, then LINC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTI
1D Price
Change %
UTI100%
+5.74%
LINC - UTI
66%
Loosely correlated
+4.55%
AZZ - UTI
49%
Loosely correlated
-1.51%
APEI - UTI
48%
Loosely correlated
+2.84%
PRDO - UTI
46%
Loosely correlated
+5.21%
BV - UTI
46%
Loosely correlated
-3.54%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KROS9.330.16
+1.74%
Keros Therapeutics
BSBR4.940.03
+0.61%
Banco Santander (Brasil) SA
ASO70.39-0.79
-1.11%
Academy Sports and Outdoors
CRML5.82-0.23
-3.80%
Critical Metals Corp
IFBD1.59-0.09
-5.36%
Infobird Co Ltd